NL7510703A - THIAMINE DISULPHIDE ORROTATE AND THE PHARMACEUTICAL APPLICATION THEREOF. - Google Patents

THIAMINE DISULPHIDE ORROTATE AND THE PHARMACEUTICAL APPLICATION THEREOF.

Info

Publication number
NL7510703A
NL7510703A NL7510703A NL7510703A NL7510703A NL 7510703 A NL7510703 A NL 7510703A NL 7510703 A NL7510703 A NL 7510703A NL 7510703 A NL7510703 A NL 7510703A NL 7510703 A NL7510703 A NL 7510703A
Authority
NL
Netherlands
Prior art keywords
orrotate
pharmaceutical application
disulphide
thiamine
thiamine disulphide
Prior art date
Application number
NL7510703A
Other languages
Dutch (nl)
Original Assignee
Helm Karl O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helm Karl O filed Critical Helm Karl O
Publication of NL7510703A publication Critical patent/NL7510703A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D415/00—Heterocyclic compounds containing the thiamine skeleton
NL7510703A 1974-09-12 1975-09-11 THIAMINE DISULPHIDE ORROTATE AND THE PHARMACEUTICAL APPLICATION THEREOF. NL7510703A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742443979 DE2443979A1 (en) 1974-09-12 1974-09-12 THIAMINE DISULFIDE OROTATE

Publications (1)

Publication Number Publication Date
NL7510703A true NL7510703A (en) 1976-03-16

Family

ID=5925726

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7510703A NL7510703A (en) 1974-09-12 1975-09-11 THIAMINE DISULPHIDE ORROTATE AND THE PHARMACEUTICAL APPLICATION THEREOF.

Country Status (10)

Country Link
JP (1) JPS5161614A (en)
AU (1) AU8472375A (en)
BE (1) BE833351A (en)
CH (1) CH602666A5 (en)
DE (1) DE2443979A1 (en)
FR (1) FR2284328A1 (en)
GB (1) GB1477263A (en)
NL (1) NL7510703A (en)
SE (1) SE7510137L (en)
ZA (1) ZA755816B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8034823B2 (en) 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
DE102009025549A1 (en) * 2009-06-15 2010-12-16 Werth Akupunktur Center Composition for the transport of orotic acid across the blood-brain barrier

Also Published As

Publication number Publication date
FR2284328B1 (en) 1979-09-14
AU8472375A (en) 1977-03-17
BE833351A (en) 1975-12-31
FR2284328A1 (en) 1976-04-09
ZA755816B (en) 1976-08-25
SE7510137L (en) 1976-03-15
JPS5161614A (en) 1976-05-28
GB1477263A (en) 1977-06-22
CH602666A5 (en) 1978-07-31
DE2443979A1 (en) 1976-04-29

Similar Documents

Publication Publication Date Title
NL7510342A (en) SUBSTITUTED PURIN COMPOUNDS AND PHARMACEUTICAL USES THEREOF.
NL7512201A (en) OBJECT WITH WASH-CARE PROPERTIES.
NL7509917A (en) THE HALOGENATION METHOD.
NL7504077A (en) FASTENER.
NL7513622A (en) ROLE.
NL172727C (en) JOINT DOPROSTHESIS.
SE7503523L (en) TIENYL AND TIETYL ASSOCIATIONS ..
SE7509201L (en) OIL AND THE PROCEDURE FOR ITS PRODUCTION.
NL7503632A (en) PHENOLESTERS AND PHENOLAMIDS.
NL7415505A (en) FASTENER.
NL179104C (en) ELECTROSTATIC TRANSDUCENT.
NL7513098A (en) 3.4-DIHYDROCARBOSTYRIL DERIVATIVES.
NL7412151A (en) DIAZOTYP MATERIAL.
NL161056C (en) TOTAL JOINT DOPROSTHESIS.
NL7510781A (en) ALKANOLAMINS AND METHODS FOR THE PREPARATION THEREOF.
IT1052545B (en) 2 1 3 BENZOTIADIAZIN.4.ON 2 2 BIOSIDES N N REPLACED
NL7505174A (en) PHARMACEUTICAL MIXTURES.
NL7510703A (en) THIAMINE DISULPHIDE ORROTATE AND THE PHARMACEUTICAL APPLICATION THEREOF.
DK367275A (en) BASIC SUBSTITUTED 3,4-DIHYDRO-2H-ISOQUINOLIN-1-THIONER AND PROCEDURES FOR THE PREPARATION
NL7409462A (en) DRAINE MATERIAL.
DK418775A (en) SUBSTITUTED 2,6-METHANO-3-BENZAZOCHINES AND PROCEDURES FOR THE MANUFACTURE
NL7504165A (en) ANTIDIABETICS.
NL7504704A (en) MEDICINE.
DK484375A (en) 3,7-DIMETHYL-3-HYDROXY-6-OCTENNITRIL AND PROCEDURES FOR THE MANUFACTURE
BE828066A (en) 3,4-DICARBOXYCEPHALOSPORINS AND DERIVATIVES

Legal Events

Date Code Title Description
BV The patent application has lapsed